EnzymeBioSystems Financing Cash Flow
EnzymeBioSystems reported Financing Cash Flow of $555.96 thousand for the 9-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2018-05-08
- EnzymeBioSystems net cash provided by (used in) financing activities for the quarter ending 2018-03-31 was $0.00.
- EnzymeBioSystems net cash provided by (used in) financing activities for the quarter ending 2017-12-31 was $355.50K.
- EnzymeBioSystems net cash provided by (used in) financing activities for the quarter ending 2017-09-30 was $200.46K.
- EnzymeBioSystems net cash provided by (used in) financing activities for the quarter ending 2013-03-31 was $0.00.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 42 month | Net Cash Provided by (Used in) Financing Activities 45 month |
|---|---|---|---|---|---|
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-08 | $355.50K derived: sum of 2 quarters · filed 2018-05-08 | $555.96K 10-Q · filed 2018-05-08 | ||
| 2017-12-31 | $355.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-21 | $555.96K 10-Q · filed 2018-02-21 | |||
| 2017-09-30 | $200.46K 10-Q · filed 2017-11-13 | ||||
| 2013-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-14 | $60.00K 10-Q · filed 2013-05-14 | $258.89K 10-Q · filed 2013-05-14 | ||
| 2012-12-31 | $60.00K 10-Q · filed 2013-02-13 | $258.89K 10-Q · filed 2013-02-13 |